[Skip to Content]
[Skip to Content Landing]

High vs Low Dose Chloroquine Diphosphate For COVID-19

Educational Objective
To understand the risks of high dose Chloroquine Diphosphate
0.25 Credit CME

Steven M. Bradley, MD, MPH joins JAMA Network editors to discuss a randomized clinical trial evaluating the safety and efficacy of 2 chloroquine diphosphate dosages in patients with severe coronavirus disease 2019 (COVID-19). JNOLive is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow JAMA Network Open on Facebook, Twitter and YouTube.

Sign in to take quiz and track your certificates

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Close
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close